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Abstract  
Reptin and Pontin are related ATPases associated in stoichiometric amounts in several 
complexes involved in chromatin remodeling, transcriptional regulation and telomerase 
activity. We found that Reptin was upregulated in hepatocellular carcinoma (HCC) and that 
down-regulation of Reptin led to growth arrest. We show here that Pontin mRNA is also 
upregulated in human HCC 3.9 fold as compared to non-tumor liver (p = 0.0004). Pontin 
expression was a strong independent factor of poor prognosis in a multivariate analysis. As 
for Reptin, depletion of Pontin in HuH7 cells with siRNAs led to growth arrest. Remarkably, 
Pontin depletion led to down-regulation of Reptin as shown with Western blot, and 
conversely. Whereas siRNAs induced a decrease of their cognate mRNA targets, they did not 
affect the transcripts of the partner protein. Translation of Pontin or Reptin was not altered 
when the partner protein was silenced. However, pulse-chase experiments demonstrated that 
newly synthesized Pontin or Reptin stability was reduced in Reptin or Pontin depleted cells; 
respectively. This phenomenon was reverted upon inhibition of proteasome or ubiquitin-
activating enzyme (E1). In addition, proteasome inhibition could partly restore Pontin steady-
state levels in Reptin-depleted cells, as shown by Western blot. This restoration was no more 
observed when cells were also treated with cycloheximide, thus confirming that proteasomal 
degradation in this setting was restricted to newly synthesized Pontin. Conclusion : Reptin 
and Pontin protein levels are strictly controlled by a post-translational mechanism involving 
proteasomal degradation of newly synthesized proteins. These data demonstrate a tight 
regulatory and reciprocal interaction between Reptin and Pontin, which may in turn lead to 
the maintenance of their 1:1 stoichiometry.  
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Hepatocellular carcinoma (HCC) is the main type of primary liver cancer. It is the fifth most 
common cancer worldwide and bears a very poor prognosis, mainly because of the lack of 
efficient therapy. Looking for new targets, we performed a comparative proteomic analysis 
between HCC and peri-tumoral liver, which led to the discovery of many deregulated proteins 
(1), including Reptin. Reptin overexpression was associated with a poor prognosis, and we 
demonstrated that Reptin was required for HCC cell viability and growth, and that Reptin 
overexpression conferred a greater ability to tumor cells for growth in xenografts (2). 
Reptin (TIP48, TIP49b, RuvBL2, TAP54β, ECP-51) and Pontin (or TIP49, RuvBL1, 
TAP54α, ECP-54) are closely-related members of the AAA+ family of ATPases (ATPases 
Associated with various cellular Activities (3)) that show remarkable conservation from yeast 
to human. Due to their participation in several distinct multi-protein complexes (reviewed in 
(4, 5)), they are involved in chromatin remodeling (6-8), transcriptional regulation (6, 9, 10), 
DNA damage repair (7, 11), snoRNA biogenesis (12) and telomerase activity (13). Because 
Reptin is usually associated with Pontin in complexes where they are present in stoichiometric 
amounts (7, 8, 10, 14-19), we studied Pontin expression and function in HCC. We found that 
Pontin was also up-regulated in HCC and unexpectedly that Pontin and Reptin expression was 
co-regulated via a novel post-translational mechanism. 
 
Experimental procedures 
 
Liver samples and real-time RT-PCR 
Samples came from resected or explanted livers with HCC of patients treated in Bordeaux 
from 1992 to 2005. Fragments of fresh tumor and non-tumor liver tissues (taken at a distance 
of at least 2 cm from the tumor) were either snap-frozen in liquid nitrogen and stored at -
80°C, or fixed with formalin and embedded in paraffin. 104 HCC samples (supporting Table 
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1) were used for real-time RT-PCR analysis. 18 non-tumor liver samples were used as a 
control group. RNA extraction and real-time RT-PCR were performed as described (2, 20). 
Pre-developed sequence detection reagents specific for human RUVBL1 gene (Applied 
Biosystems, Courtaboeuf, France) were used as described (20) using the 2-∆∆CT method (21). 
Gene expression results were normalized to internal control ribosomal 18S.  
 
Immunohistochemistry 
This was done as described (2) using a mouse monoclonal Pontin antibody (22) diluted to 1.6 
µg/µl. 
 
Transient transfection of small interfering RNA (siRNA) 
We used two targeting siRNAs for each Reptin (R1 and R2 (2)) and Pontin mRNAs (P1 and 
P2, Supporting Table 2). Controls were either scrambled R2 and P2 sequences, or the GL2 
siRNA targeting Firefly luciferase (MWG, Ebersberg, Germany). siRNAs were transfected at 
a concentration of 125nM with Lipofectamine (Invitrogen, Cergy Pontoise, France).  
 
Cell proliferation assay and caspase 3 activity measurement 
Cells were counted with a Coulter counter (Beckman Coulter, Villepinte, France) in duplicate 
wells. DNA synthesis was measured by the quantification of bromodeoxyuridine (BrdU) 
incorporation, and caspase 3 activity with a colorimetric assay (2). 
 
Western blot 
Cell extracts were prepared in RIPA buffer (23). We used Reptin, β-catenin (BD Biosciences, 
Pharmingen, Le Pont de Caix, France), FLAG-M2, β-actin (Sigma-Aldrich, Saint-Quentin 
Fallavier, France) mouse monoclonal, and Pontin rabbit polyclonal (ProteinTech, Chicago, 
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IL) antibodies. Primary antibodies were detected by horseradish peroxidase conjugated, or 
infrared dye-labeled secondary antibodies (LI-COR, Lincoln, NE). Detection was achieved 
with the ECL kit (GE Healthcare, Saclay, France) or the Odyssey IR imaging system (LI-
COR), respectively. 
 
Polyribosome fractionation 
KGL2 and KR2 cells lines stably expressing an shRNA targeting Firefly luciferase or Reptin, 
respectively, in a doxycycline-dependent manner (Supporting Methods), were cultured with 
or without doxycycline. Cycloheximide (100 µM) was added ten minutes before cell lysis. 
Sucrose-gradient fractionation and polysome-associated RNA purification were as described 
(24). RNAs were analyzed by cDNA synthesis and PCR amplification. 
 
Metabolic labeling and immunoprecipitation  
KGL2 and KR2 cells were stably transduced with a lentiviral vector coding HA-Pontin 
resulting in KGL2-HAP and KR2-HAP cell lines (Supporting Methods). Similarly, KP2 cells 
expressing the P2 Pontin shRNA (Supporting Methods), were transduced with Flag-Reptin 
(2), resulting in KP2-FR cells. Cells were incubated in Methionine/Cysteine-free medium for 
30 min before pulse labeling with 150 µCi/ml EXPRE35S35S Protein Labeling Mix (Perkin 
Elmer, Courtaboeuf, France) for 15 min at 37°C. Cells were washed then scraped in lysis 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 4 mM EDTA, 1% Triton, 1% SDS) 
supplemented with protease inhibitor cocktail (Roche, Meylan, France). The amount of 
radiolabeled TCA-precipitated material was measured by scintillation counting. 
For pulse-chase experiments, cells were labeled with 100 µCi/mL EXPRE35S35S Protein 
Labeling Mix for 1h, washed with medium supplemented with 2 mM cysteine/methionine, 
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and cultured for various times in this chase medium supplemented with the indicated agents 
before harvesting. 
Cell extracts were diluted in lysis buffer without SDS and incubated for 2 hours at 4°C with 
monoclonal anti-HA-Agarose or anti-Flag M2 beads (Sigma-Aldrich). The beads were 
washed 5 times with lysis buffer and eluted with Laemmli sample buffer. Eluates were 
separated on a 10% SDS-PAGE. In some cases, Pontin was precipitated with a polyclonal 
anti-Pontin antibody.  
Signals from radiolabeled protein bands were acquired in an Instant-Imager (Packard, Perkin-
Elmer). Protein degradation rate is expressed as half-life (t1/2), the time where 50% of the 
protein is degraded. The results are expressed as mean ± SEM of five to six independent 
determinations. 
 
Statistical analysis 
Statistical analyses were performed using the 2-tailed Student t test, or 1-way analysis of 
variance (ANOVA) when comparing multiple means. Statistical significance was set at a p 
value of less than 0.05. Correlations between mRNA levels of expression and qualitative 
variables were calculated with the non-parametric Kruskal- Wallis test with STATA software 
(Stata Corp., College Station, TX). The ages of patients and diameters of the tumors were 
partitioned with a median. For survival analysis, expression data were logarithm 10-
transformed and dichotomized according to the median. Survival comparisons were done by 
log-rank test. Survival curves were obtained by the Kaplan-Meier method. Multivariate 
analyses were performed using Cox model. All survival analyses were performed using 
STATA software 8.2. 
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Results 
 
Pontin is overexpressed in human HCC 
There was a 3.9-fold increase in Pontin transcripts in HCC as compared to non-tumor livers 
(Fig. 1A, p<0.0004). Pontin mRNA levels were highly correlated with those of Reptin mRNA 
(r2 = 0.78, p < 0.0001, Fig. 1B). Immunohistochemistry confirmed the overexpression of 
Pontin in HCC with the same pattern as Reptin, and showed that, similar to Reptin (2), Pontin 
was partly localized to the cytoplasm of tumor cells (Fig. 1C-E). Pontin mRNA levels were 
correlated with features of poor prognosis : levels were higher in large tumors (> 60 mm, p = 
0.026), in tumors with vascular embolism (p = 0.047), portal invasion (p = 0.008), or 
chromosomal instability (fractional allelic loss > 0.128, p = 0.02), in patients with early 
relapse following curative surgery (p = 0.001) or who died within 3 years of surgery (p = 
0.001). A significant shorter disease-free survival in patients with high Pontin level was 
observed as compared to those with low level (Fig. 1F, p = 0.0022). Most importantly, using a 
Cox model multivariate analysis, high Pontin mRNA levels remained associated with shorter 
disease-free survival after adjustment for age, gender, tumor diameter and the presence of 
vascular embolism (Hazard Ratio = 3.9, 95% CI = [1.9-8.0], p=0.003). 
 
Pontin silencing reduced cell proliferation and induced apoptosis 
Pontin mRNA level was significantly reduced with P1 (70% ± 13%) and P2 (77% ± 12%) 
siRNAs (Fig. 2A). The siRNAs also greatly decreased Pontin protein expression (78.6% ± 
6.9% with P1 and 87.7% ± 9.0% with P2) (Fig. 2B). 
Starting from Day 3 after transfection, the growth of cells transfected with Pontin siRNAs 
strikingly decreased (Fig. 2C). This was associated with both reduced DNA synthesis, 
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evidenced by decreased BrdU incorporation, and increased apoptosis, demonstrated by an 
increased caspase 3 activity (Fig. 2D). 
 
Concomitant down-regulation of Reptin and Pontin 
Because findings with Pontin silencing were reminiscent of those we obtained previously 
upon Reptin silencing, we evaluated Reptin expression after transfection of Pontin siRNAs. 
Surprisingly, Reptin protein level was markedly reduced after transfection of P1 or P2 
compared to control siRNA. The reciprocal observation was done in cells transfected with the 
Reptin-specific R1 and R2 siRNAs where Pontin protein level was also decreased (Fig. 3A-
B). Because of the significant homology between Reptin and Pontin, we performed extensive 
control experiments that allowed excluding cross-reactivity of antibodies (Supporting Fig. 1).  
 
To rule out off-target effects of siRNAs, we used a rescue strategy. Cell lines resistant to 
siRNAs were established by transduction of lentiviral vectors bearing either HA-Pontin or 
Flag-Reptin cDNA in which silent mutations have been introduced in the sequence targeted 
by the P2 or R2 siRNAs (Supporting Fig. 2). Reptin protein expression was no more 
decreased by P2 siRNA in P2-resistant cells, whereas it was reduced as expected upon 
transfection of P1 siRNA (Fig. 3C). Similarly, Pontin expression was not affected in cells 
expressing FLAG-Reptin resistant to the R2 siRNA (Fig. 3D). Altogether, these results 
showed that the down-regulation of Pontin was a direct consequence of the silencing of 
Reptin and reciprocally. 
 
We then asked if our findings were specific of HuH7 cells. We examined the consequences of 
Reptin or Pontin silencing in another human liver cell line (HepG2), in human breast cancer 
cells (MCF7), in human prostatic cancer cells (LNCap) and in Hela cells. We also tested the 
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co-extinction of Pontin after transfection of the R2 siRNA in mouse (Hepa 1-6) or rat 
hepatoma cells (FAO). In every case, we observed a concomitant reduction of Reptin and 
Pontin protein levels (Supporting Fig. 3). These results argued in favor of a general rather 
than a cell-specific process for regulation of Pontin and Reptin expression. 
 
Reptin silencing does not decrease Pontin mRNA level (and reciprocally) 
Reptin and Pontin interact with transcription factors and bind to gene promoters (reviewed in 
(4)). We thus hypothesized that they could regulate reciprocally their expression through a 
transcriptional mechanism. However, transfection of Pontin siRNAs did not alter Reptin 
mRNA levels, whereas as expected, Pontin mRNA decreased. Reciprocally, Reptin, but not 
Pontin mRNA levels were efficiently silenced with Reptin siRNAs (Fig. 4A-B).  
As an additional control, we tested whether Reptin produced from an mRNA devoid of its 
natural regulatory sequences would also be depleted upon transfection of a Pontin siRNA. We 
used HuH7 cells stably expressing N-term FLAG-tagged Reptin from the viral MND 
promoter (2). We found that the level of both endogenous and Flag-tagged Reptin was 
decreased after transfection of Pontin specific siRNAs (Supporting Fig. 4A). We obtained 
similar results with HeLa cells expressing FLAG/HA-tagged Reptin or Pontin from the CMV 
promoter (Supporting Fig. 4B).  
 
Altogether, these experiments allow concluding that the reduction of Reptin or Pontin protein 
levels upon silencing of the respective binding partner is not related to a transcriptional effect, 
and thus occurs by a post-transcriptional mechanism. 
 
Reptin silencing does not alter Pontin mRNA translation (and reciprocally) 
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Given the pleiotropic role of Reptin and Pontin, we hypothesized that they might regulate 
their partner’s translation. This was tested using polyribosome fractionation and RT-PCR 
analysis in HuH7 cell lines stably expressing shRNAs targeting either Firefly luciferase 
(KGL2) or Reptin (KR2), in a doxycycline-dependent manner (Supporting Fig. 5). The 
polysomal distribution of Pontin mRNA was analyzed after 4 days of culture with or without 
doxycycline (Fig. 5A-B). In KGL2 cells, Reptin and Pontin transcripts exhibited a similar 
profile and were found all along the gradient, with an enhancement in the heaviest fractions, 
associated with polyribosomes. As expected, in doxycycline-treated KR2 cells, Reptin mRNA 
became barely detectable, whereas the profile of Pontin mRNA was unchanged as compared 
to that in KGL2 cells, and its distribution over the fractions was similar to the profile of 
GAPDH mRNA. When cells were incubated with puromycin for one hour prior to extraction, 
the profile of Pontin and GAPDH mRNAs shifted from heavy fractions to the top of the 
gradient (Fig. 5B). Because puromycin is a polypeptide chain terminator that causes 
premature termination of translation, our results demonstrate a genuine association of Pontin 
mRNA with polyribosomes, even in conditions where Reptin is depleted. 
 
To make sure that Pontin mRNA was indeed actively translated, we performed metabolic 
labeling after 4 days of culture with doxycycline using cells stably expressing HA-Pontin 
(KGL2-HAP and KR2-HAP). After a 15 min pulse of radiolabeled methionine/cysteine, the 
level of 35S incorporation into newly synthesized proteins was not different between KGL2-
HAP and KR2-HAP cells (78.8% ± 4.3% vs 71.6 ± 6.8%, respectively), suggesting no gross 
alteration in overall protein biosynthesis in Reptin silencing conditions. After 
immunoprecipitation with anti-HA antibodies, the label accumulated in a 55-kDa band 
confirmed to be the full-length HA-Pontin polypeptide since it was reactive with an antibody 
against Pontin (Fig. 5C). When Reptin shRNA expression was induced in KR2-HAP cells, the 
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amount of labeled HA-Pontin immunoprecipitated after a 15 min pulse was 98% of the 
control. This experiment showed that the decrease in HA-Pontin expression in cells 
expressing Reptin shRNA was not the consequence of a defective translation. Therefore, the 
association of Pontin mRNA with polyribosomes and the completion of HA-Pontin 
translation argued in favor of a post-translational regulation that explains the co-depletion of 
Pontin and Reptin. In reciprocal experiments, we also found that Pontin silencing did not alter 
Reptin translation, although Reptin silencing with R1 siRNA did reduce Reptin translation as 
expected (Fig. 5D). 
 
Reptin silencing induces Pontin destabilization 
Because Pontin and Reptin form a stoichiometric complex, we hypothesized that down-
regulation of one of the two partners could disturb this stoichiometry and lead to post-
translational destabilization of the binding partner. We thus measured Pontin half-life using 
metabolic labeling-chase experiments. Newly synthesized HA-Pontin was less stable upon 
Reptin silencing as shown by a significantly reduced half-life as compared to control (t1/2 = 
66.6 ± 7.6 vs 118 ± 21 min, p = 0.002) (Fig. 6A, 6C). Because the proteasome is the major 
intracellular proteolytic machinery in higher eukaryotic cells, we tested its involvement using 
specific inhibitors. Fig. 6B-C shows that MG132 was able to prolong the half-life of HA-
Pontin in both Reptin-repleted and depleted conditions. The effect of Reptin depletion was 
specific since it did not alter the half-life of calnexin tested as a control (Fig. 6D). 
 
We then asked if proteasome inhibitors could restore Pontin steady-state level in Reptin-
depleted cells. We performed many experiments using a variety of experimental settings. For 
instance, Fig. 7A shows an experiment where, three days after induction of Reptin shRNA 
expression, HuH7 cells were treated with MG132 or epoxomycin for 4h. This did not modify 
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the co-depletion although effective inhibition of the proteasome was confirmed by the 
accumulation of higher molecular weight forms of β-catenin, a proteasome target (25). 
Similar results were seen when using other MG132 concentrations, duration of treatment, or 
with other inhibitors such as clasto-Lactacystin-β-lactone (not shown). We hypothesized that 
if the stabilizing effect of proteasome inhibition was restricted to newly synthesized protein 
chains, our experiments might not be sensitive enough to detect an accumulation of proteins 
within the short time course of the experiments. We thus repeated them using HuH7 cells that 
stably express HA-Pontin. These cells have high levels of Pontin mRNA (not shown), and 
interestingly a higher rate of Pontin translation than control cells (Fig. 7B). They do however 
overexpress very little Pontin at the protein level, reminiscent of our previous results with 
Flag-Reptin (2) (Fig. 7B). When these cells were treated with MG132 for 4 hours, we could 
detect a significant increase in Pontin protein levels both in basal conditions and when Reptin 
was previously depleted upon shRNA induction with doxycycline (Fig. 7C-D). On the other 
hand, the low level of Reptin consecutive to R2 shRNA induction in doxycycline-treated cells 
was not increased by MG132. Similar results were obtained when the proteasome was 
inhibited with 2.5µM epoxomycin (not shown).  
 
Altogether, these results suggested that the restoration seen with proteasome inhibition was 
restricted to the pool of freshly translated protein. This hypothesis was tested in experiments 
where, following Reptin depletion, proteasome inhibition with MG1342 or epoxomycin was 
done in the absence or in the presence of cycloheximide that blocks new protein synthesis. As 
shown in Fig. 7E-F, cycloheximide treatment prevented the restoration of Pontin levels in 
these conditions. 
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Since in most cases proteins are targeted to the proteasome following poly-ubiquitylation, we 
examined the stability of newly synthesized Pontin in the presence of the ubiquitin activating 
enzyme inhibitor UBEI-41 (Biogenova). We found indeed that newly synthesized Pontin 
stability was enhanced in cells with Reptin depletion when they were treated with UBEI-41 
(Fig. 8A). We also performed the reverse experiment. We first showed that the stability of 
newly synthesized Reptin was reduced upon Pontin silencing (Fig. 8D, compare lanes 2 and 
6), an effect reverted in great part by proteasome inhibition (Fig. 8D). Furthermore, Reptin 
stability in Pontin-depleted cells was also largely restored following inhibition of ubiquitin 
activating enzyme (Fig. 8D). These data proved that an ubiquitylation step was involved in 
the destabilization of Pontin and Reptin in this setting. 
We next attempted to detect whether Pontin and Reptin underwent polyubiquitylation upon 
silencing of their partner. Because endogenous ubiquitin might be limiting, and in order to 
maximize the sensitivity of detection, we transduced KR2 cells with adenoviral vectors 
(kindly provided by H. Wodrich, Bordeaux) expressing either HA-ubiquitin and GFP, or GFP 
alone. After 3 days with or without Dox, the proteasome was inhibited with epoxomycin in 
order to allow accumulation of ubiquitylated proteins, and ubiquitin was precipitated using the 
HA tag. Western blot with a Pontin antibody failed to reveal ubiquitylated Pontin whereas 
ubiquitylated β-catenin was indeed detected (Supporting Fig. 6A). The same results were 
obtained when looking for Reptin ubiquitylation in KP2-FR cells (Supporting Fig. 6B). 
 
Discussion  
 
We show that Pontin is overexpressed in a large series of human HCC. High levels of Pontin 
mRNA were associated with features of poor prognosis. Using a multivariate analysis, we 
even found that Pontin level was an independent factor of poor prognosis when taking into 
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account other poor prognosis factors including the presence of vascular embolism. In 
addition, in vitro experiments showed that Pontin was required for HCC cell growth and 
viability. All these findings, also including the cytoplasmic localization of Pontin in tumor 
cells, are highly reminiscent of those that we obtained with Reptin (2) and are in keeping with 
the known association of Pontin with Reptin into functional complexes (4, 5).  
 
Surprisingly, silencing experiments led to a similar co-depletion of Pontin and Reptin, as 
recently found in HeLa cells (13). Our results were extended to a series of human cells from 
liver and non-liver origin and to other species, suggesting that co-depletion of Reptin and 
Pontin is a general finding. We demonstrate that Pontin and Reptin co-depletion is linked to a 
post-translational regulation since no changes in mRNA levels nor in translation were 
observed following silencing. On the other hand, we show that the stability of newly 
synthesized Pontin is reduced when Reptin is previously depleted, and reciprocally. This 
defect can be reverted when using a proteasome inhibitor. In addition, we show that 
proteasome inhibition is able to increase Pontin steady-state level whether Reptin levels are 
high or low. Proteasome inhibition had on the other hand no effect on the residual low levels 
of Reptin consecutive to RNAi. Together with our results with cycloheximide, this suggests 
that the restoration of Pontin levels due to proteasome inhibition is mainly the consequence of 
stabilization of newly translated Pontin, whereas no effect is seen for Reptin which translation 
is impaired because of RNAi. We suggest that Pontin and Reptin heteromers are formed 
immediately upon completion of translation, likely co-translationnally. In that case, in the 
absence of its partner, newly translated Pontin or Reptin cannot be correctly folded and is 
targeted for proteasomal degradation. This is also in agreement with our data showing that 
Reptin and Pontin depletion follow identical kinetics upon use of any siRNA (Supporting Fig. 
7). It is also possible that Pontin and Reptin act as chaperones for each other. A chaperone 
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role can be inferred from their presence in a HSP90 complex conserved in human and yeast 
(26, 27), their role in the assembly of the Ino80 complex in yeast (28), and is coherent with 
the fact that many other members of the AAA+ family are indeed bona fide chaperones (3). In 
most cases, proteins undergo proteasome degradation following prior polyubiquitylation. 
Polyubiquitylation involves an ordered set of reactions beginning with activation of ubiquitin 
by the ubiquitin-activating enzyme E1 (29). We thus used an E1 inhibitor and found that the 
stability of both Pontin and Reptin was enhanced. We were however unable to directly detect 
polyubiquitylation of any of them even when ubiquitin was greatly overexpressed and 
proteasome inhibited. It may be that the sensitivity of ubiquitylation detection is still 
insufficient or that there is an intermediary protein that is ubiquitylated and regulates Pontin 
and Reptin turnover (30). Further experiments are needed to clarify this point.  
 
Besides the co-depletion, results from our study also shed light on our previous observation 
that transduction of cells with a lentiviral vector coding Flag-tagged Reptin induced very little 
protein overexpression despite highly increased mRNA levels (2). We obtained similar data 
here with a vector coding HA-Pontin, and found that inhibition of proteasome enhanced the 
stability of newly synthesized Pontin and allowed a higher accumulation of Pontin (Fig. 7C-
D). This gives support to the hypothesis that the lack of high-level protein expression is 
explained by a degradation of the newly translated protein that cannot find its binding partner. 
 
A co-depletion of proteins engaged in functional complexes has been already shown for 
instance in the case of the Ku70-Ku80 heterodimer (31) or the γ-secretase complex (32). 
However, in no case were full mechanistic data provided. In addition, our findings are unique 
in that we show that destabilization of the protein partner intervenes at an early post-
translational stage. 
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From our findings, one would expect that the depletion of either protein would result in the 
same cellular phenotype. This is indeed what was observed in our experiments when 
comparing depletion of Reptin (2) and Pontin (this study) on cell growth and apoptosis, and 
also by others on the formation of RAD51 nuclear foci after DNA damage in prostate cancer 
cells (11). In the yeast, genome-wide microarray analysis after acute deletion of either protein 
showed a striking correlation between the genes regulated by each protein (6). More 
generally, knockdown, inactivation or deletion of either gene in Drosophila (10) or yeast (33) 
resulted in a similarly lethal phenotype. These data have been interpreted as Pontin and Reptin 
having non-redundant functions. We suggest that they could be re-interpreted on the basis of 
the co-depletion of both proteins. Still, it is likely that Pontin and Reptin have some unique 
functions as suggested by several observations. Indeed, whereas Pontin depletion with 
siRNAs led to spindle defects in Drosophila S2 and HeLa cells, Reptin siRNAs had no effect 
(34). Pontin and Reptin also antagonistically modulate β-catenin transcriptional activity (10, 
14, 16, 22), likely because they are incorporated into different complexes and differentially 
recruited onto target promoters (9, 35). These apparently unique functions may be due to a 
small pool of Pontin and Reptin not engaged in heteromeric complexes but present as 
monomers of homo-oligomers. Although structural studies suggest mostly hetero-complex 
formation (17, 18), they do not exclude the possibility of other forms (18).  
 
In summary, Pontin, like Reptin, is overexpressed in HCC and is required for HCC growth 
and viability. We demonstrate that the expression of both proteins is strictly co-regulated by a 
post-translational mechanism involving the proteasomal degradation of newly synthesized 
proteins. We also found that Pontin and Reptin expression are highly correlated at the mRNA 
level in HCC thus suggesting some additional co-regulation at the mRNA level. Altogether, 
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the whole data indicate the importance to maintain a strict control of the stoichiometry 
between Pontin and Reptin for proper cell homeostasis and likely for their role in 
carcinogenesis.  
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Figure legends 
Figure 1. Expression of Pontin in human hepatocellular carcinoma 
(A) Pontin mRNA levels were measured with real-time RT-PCR in 104 HCC and 18 non-
tumoral livers (NT). Gene expression results were normalized to internal control ribosomal 
18S. The graph shows the mean ± 1 SD of mRNA levels. (B) Correlations between Pontin 
and Reptin mRNA levels in HCC and non-tumor (NT) samples. (C) Pontin immunostaining at 
the junction between the HCC (left) and the surrounding non-tumoral liver that is separated 
from the tumor by a fibrous capsule. Staining appears as a brown color. The inset shows a 
consecutive section stained with a control IgG. (D) Reptin immunostaining on a consecutive 
section. (E) Pontin immunostaining on a high-power view of the tumor where an intense 
cytoplasmic staining is detectable. (F) Disease-free survival (DFS) curves according to Pontin 
mRNA levels. Log-rank test comparison of low versus high levels gave a P value at 0.0022. 
 
Figure 2. Efficiency and effects of silencing of Pontin by siRNAs in HuH7 cells 
(A) Relative expression of Pontin mRNA in HuH7 24h post-transfection of Pontin siRNA (P1 
and P2) or control siRNA (scP). Gene expression was measured by real-time RT-PCR. 
Results are normalized on the basis of the expression of GAPDH and on the level of the non-
transfected cells (NT). The graph shows the mean ± 1 SD of 3 independent experiments. (B) 
Western blot showing Pontin expression 3 days after siRNA transfection in HuH7. The same 
blot was re-hybridized with a β-actin antibody. (C) Cell proliferation was measured at 
indicated times after siRNAs transfection. Shown are the means ± 1 SEM of 3 experiments 
conducted in duplicate. Proliferation of P1 and P2 transfected cells was significantly different 
in comparison with controls (NT and scP) (p<0.001). (D) BrdU incorporation and caspase 3 
activity measured in cells after transfection of siRNA against Pontin (P1 and P2) or scrambled 
P2 duplexes (scP). Values are means ± 1 SD of three experiments. BrdU incorporation was 
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significantly reduced and caspase-3 activity increased in P1 and in P2 transfected cells 
compared to scrambled-transfected cells (p<0.001 and p<0.05, respectively).  
 
Figure 3. Silencing of Reptin or Pontin by specific siRNAs leads to down-regulation of 
both proteins. 
(A) Western blot of Pontin and Reptin expression in HuH7 cells three days after transfection 
of siRNAs targeting Reptin (R1 and R2), Pontin (P1 and P2) or Luciferase (GL2). (B) The 
graph shows the relative amounts of Pontin and Reptin. All values are the mean ± 1SD of at 
least 3 independent experiments. (C) HuH7 cells expressing HA-Pontin (wt) or HA-Pontin 
resistant to P2 siRNA (res) were transfected with control (GL2) or Pontin siRNAs (P1 or P2). 
Expression of Pontin and Reptin was analyzed by western blot. In cells expressing HA-Pontin 
resistant to P2, Reptin level was not decreased after transfection of P2. In contrast, P1 siRNA 
depleted together Pontin, HA-Pontin and Reptin (note that HA-Pontin cannot be distinguished 
from endogenous Pontin on these gels). (D) HuH7 cells expressing Flag-Reptin resistant to 
R2 siRNA were transfected with control (GL2) or Reptin siRNAs (R1 or R2). In cells 
expressing Flag-Reptin resistant to R2, the level of Pontin was not decreased after transfection 
of R2. In contrast, R1 siRNA depleted together Reptin, Flag-Reptin and Pontin. The arrow 
indicates the upper band revealed with the anti-Reptin antibody, corresponding to Flag-
Reptin. 
 
Figure 4. Expression of Reptin and Pontin transcripts following silencing 
(A) Total RNA was purified 24h after transfection of Pontin (P1 and P2) or Reptin specific 
siRNAs (R1 and R2). Scrambled P2 (scP) or R2 (scR) duplexes were used as controls. RNAs 
were used for RT-qPCR analysis of Pontin (left) or Reptin (right) mRNAs. The results are 
expressed as relative expression of Reptin and Pontin normalized to GAPDH and are the 
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mean ± 1SD of at least three independent experiments. Pontin and Reptin mRNAs were 
significantly decreased only following transfection of their targeting siRNAs (p<0.001 by 
ANOVA). (B) Same experiment performed 48 h after transfection of siRNAs.  
 
Figure 5. Distribution of Reptin and Pontin mRNA in polysomes, and translation of 
Pontin. 
(A) Representative distribution of ribosomal RNAs in a sucrose gradient visualized by 
ethidium bromide staining. RNA from each fraction was analyzed by RT-PCR. (B) 
Distribution of GAPDH, Reptin and Pontin mRNA in polysomes. KGL2 or KR2 cells that 
stably express a doxycyline-inducible shRNA against luciferase or Reptin, respectively, were 
grown with or without 0.02 µg/ml doxycycline for 3 days before cell fractionation. Polysome 
profile analyses were carried out 3 times, with similar results. (C) Normal translation of 
Pontin in Reptin-depleted cells. Cells were grown for 4 days with or without doxycyline, then 
pulsed for 15 min with [35S] methionine/cysteine. The overall profile of newly synthesized 
proteins is not altered upon Reptin depletion (top left panel). Depletion of Pontin in KR2-
HAP treated with doxycycline was shown by immunobloting with an anti-Pontin antibody 
(bottom left). HA-pontin was immunoprecipitated with anti-HA antibody. Signals from 
immunoprecipitated radiolabeled polypeptides were acquired with an Instant-Imager (top 
right). The identity of the labeled band was confirmed by immunodetection with an anti-
Pontin antibody (bottom right). As a control, no labeled polypeptide was immunoprecipitated 
with anti-HA in extracts from wild type HuH7 cells. (D) Normal translation of Flag-Reptin in 
Pontin-depleted cells. Cells were grown for 5 days after tranfection of control (GL2) , Reptin 
(R1) or Pontin (P1) siRNAs, then pulsed for 15 min with [35S] methionine/cysteine. The 
overall profile of newly synthesized proteins is not altered upon Reptin or Pontin depletion 
(top left panel). Depletion of Pontin and Flag-Reptin in Huh7 cells after transfection of R1 
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and P1 siRNAs was shown by immunobloting with anti-FLAG and anti-Pontin antibodies 
(bottom left). FLAG-Reptin was immunoprecipitated with anti-FLAG antibody. Signals from 
immunoprecipitated radiolabeled polypeptides were acquired with an Instant-Imager (top 
right). 
 
Figure 6. Half-life of Pontin 
(A) Pulse-chase analysis of HA-tagged Pontin in KR2-HAP cells in Reptin-replete (“w/o 
dox”) or Reptin-depleted conditions (“with dox”). Equal amounts of cell lysates were 
immunoprecipitated with an anti-HA antibody. Eluates were loaded onto a SDS-PAGE. As a 
control, no labeled polypeptide was immunoprecipitated with anti-HA in extracts from wild 
type HuH7 cells (lane 1). (B) Same experiment except that the chase medium was 
supplemented or not with the proteasome inhibitor MG132 (25 µM). (C) The graph shows 
relative quantitation of radiolabeled protein from at least 3 independent experiments. Counts 
from t0 were arbitrarily set at 100%. (D) Pulse-chase analysis of Calnexin half-life. Calnexin 
was immunoprecipitated from the flow-through fractions after centrifugation of anti-HA-
agarose bead, using a rabbit polyclonal anti-Calnexin antibody (36), followed by protein A-
Sepharose beads. (E) Graphical analysis of (D) following signal quantitation. 
 
Figure 7. Effect of proteasome inhibitors on the decrease in Pontin levels upon Reptin 
depletion 
(A) Western blot of Reptin and Pontin expression in KR2 cells. After three days with or 
without doxycyclin, cells were treated with 25µM MG132, 2.5 µM epoxomycin, or DMSO 
during 4 hours. The same samples were also analyzed for β-catenin expression. (B) 
Expression of Pontin in KR2-HAP cells. Left, cells were pulse-labeled and Pontin was 
immunoprecipitated. The top panel shows newly synthesized Pontin, and the bottom one total 
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Pontin. There was a 4.9 fold increase in newly synthesized Pontin in cells expressing HA-
Pontin as compared to control cells. On the right side, Western blot for Pontin. Pontin level 
was increased by only 1.2 fold in KR2 HAP cells as compared to control cells. (C) After 3 
days of culture with or without doxycycline, cells were treated for 4h with 25 µM MG132 or 
DMSO. Cell extracts were subjected to Western blot with the indicated antibodies. (D) 
Quantification of experiments shown in (C) (n = 3). (E) Treatment with cycloheximide 
prevents the restoration by MG132 of Pontin levels in Reptin-depleted cells. Cells were 
treated as in (C). In some cases (cycloheximide (CHX, 50 µM) was added at the same time 
than MG132. (F) Same as in (E) except that epoxomycin was used instead of MG132. 
 
Figure 8. Evidence for the involvement of ubiquitylation in the destabilization of Pontin 
and Reptin 
(A-B) Effect of proteasome and ubiquitin-activating enzyme inhibitors on the stability of 
newly-synthesized Pontin. HuH7 cells expressing the inducible R2 Reptin shRNA together 
with HA-Pontin (KR2-HAP) were treated or not with Dox for 3 days. Metabolic labelling and 
immunoprecipitation were as in Fig. 6. The chase period was 180 min and was done in the 
presence of 25 µM MG132, 50 µM UBEI-41 (UbeI) or DMSO (CTRL). (A) Overall pattern 
of radiolabeled neosynthesized proteins (top) and western blots for Pontin, Reptin and β-actin 
in the cell extract (bottom). (B) Detection of newly-synthesized HA-Pontin following 
immunoprecipitation with the HA antibody (top); the bottom part shows the quantification of 
two independent experiments. (C-D) Effect of proteasome and ubiquitin-activating enzyme 
inhibitors on the stability of newly-synthesized Reptin. HuH7 cells expressing the inducible 
P2 Pontin shRNA together with Flag-Pontin (KP2-FR) were treated as above, except that 
immunoprecipitation was carried out with the Flag antibody. (C) Overall pattern of 
radiolabeled neosynthesized proteins (top) and western blots for Reptin, Pontin and β-actin in 
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the cell extract (bottom). (D) Detection of newly-synthesized Flag-Reptin following 
immunoprecipitation with the Flag antibody Note that all lanes from the IP experiment come 
from the same gel and were exposed simultaneously. 
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Supporting information 
 
 
Supporting methods 
Cell culture 
HuH7 cells were cultured in Dulbecco’s modified Eagle’s medium, supplemented with 10% 
fetal bovine serum, non essential amino acids, L-glutamine, and penicillin/streptomycin in 5% 
CO2 –containing atmosphere at 37°C. 
 
Construction of cell lines with a conditional expression of Reptin or Pontin shRNA 
The Reptin siRNA sequence chosen was the R2 sequence previously described (1). For the 
construction of plasmids expressing Luciferase and Reptin-specific short hairpin RNAs, the 
following oligonucleotides were used: for luciferase, GL2-sense, 5'-
cgcgtccccCACGTACGCGGAATACTTCGAttcaagagaTCGAAGTATTCCGCGTACGTGttttt
ggaaat-3'; GL2 antisense, 5'-cgatttccaaaaaCACGTACGCGGAATACTTCGAtctcttgaaTCGA 
AGTATTCCGCGTACGTGgggga-3'; for Reptin, R2-sense, 5'-cgcgtccccGAAGATGTGGAG 
ATGAGTGAGttcaagagaCTCACTCATCTCCACATCTTCtttttggaaat-3'; R2-antisense, 5'-cga 
tttccaaaaaGAAGATGTGGAGATGAGTGAGtctcttgaaCTCACTCATCTCCACATCTTCggg
ga-3'. After denaturation at 70°C during 10 min, oligonucleotides were annealed in 100 mM 
potassium acetate, 30 mM HEPES, pH 7.4, 2mM magnesium acetate. For annealing, the 
temperature was gradually reduced to 20°C. Then, the oligonucleotides duplexes were sub-
cloned into the PLVTHM vector (2) between restriction sites Cla1 and Mlu1 downstream of 
the H1 promoter, resulting in PLVTHM-GL2 and PLVTHM-R2 vectors. 
VSV-G pseudotyped lentivectors were produced by triple-transient transfection of 293T cells 
(3). Titers were determined by the transduction of 293T cells through the serial dilution of the 
lentiviral supernatant and were analyzed for EGFP expression 5 days later.  
Finally, HuH7 cells conditionally expressing GL2- or R2- shRNA were obtained as follows. 
First, HuH7 cells were transduced with the PLVtTR/KRAB-Red lentiviral vector (2) at a 
multiplicity of infection of 5 in Dulbecco/Vogt modified Eagle’s minimal essential medium 
(DMEM)/10% fetal bovine serum (FBS) medium with 8 µg/ml protamine sulfate (Sigma, St. 
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 2 
Louis, MO). This vector drives the expression of the transcriptional repressor tTR-KRAB and 
of the marker dsRED. Then, HuH7 cells expressing tTR-KRAB were selected through dsRED 
expression in a cell sorter (FACS Aria, BD Biosciences, San Jose, CA). Secondly, HuH7 
expressing tTR-KRAB were transduced with PLVTHM-GL2 or PLVTHM-R2 at a 
multiplicity of infection of 15. The resulting cell lines were named KGL2 and KR2. The 
transduction efficiency was checked through testing for EGFP expression by flow cytometry 
after three days of cultivation in medium containing 0.02 µg/ml doxycycline. 
The KP2 cell line expressing the Pontin P2 shRNA was constructed similarly using the 
following oligonucleotides : P2 sense, 5’-cgcgtCCCCGGTGAAGTCACAGAGCTAAttcaaga 
gaTTAGCTCTGTGACTTCACCTTTTTGGAAat-3’ ; P2 5’-antisense, cgatTTCCAAAAAG 
GTGAAGTCACAGAGCTAAtctcttgaaTTAGCTCTGTGACTTCACCGGGGa-3’. 
 
Construction of cell lines expressing HA-tagged Pontin  
N-term HA-tagged Pontin cDNA was amplified by PCR from CBS-Tip49 (4) and subcloned 
in pGEM-Teasy plasmid (Promega). The cDNA was sequenced and cloned downstream of 
the MND (Myeloproliferative sarcoma virus enhancer, Negative control region Deleted, 
d1587rev primer-binding site substituted) promoter in a lentiviral vector (1). Finally, KGL2 
and KR2 cell lines were transduced with this vector at a multiplicity of infection of 2. The 
resulting cell lines were named KGL2-HAP and KR2-HAP. 
 
Construction of cell lines expressing Reptin or Pontin resistant to siRNA 
Human N-term FLAG-tagged Reptin and N-term HA-tagged Pontin cDNAs were amplified 
by PCR from CBS-Tip48 and CBS-Tip49(4) and subcloned in pGEM-Teasy plasmid. Silent 
mutations were introduced by in vitro site-directed mutagenesis using the Stratagen 
QuikChange® II XL Site-Directed Mutagenesis Kit in the regions that are targeted by 
siRNAs (Supporting Figure 2). The inserts were sequenced to verify that selected clones 
contain the desired mutations and cloned downstream of the MND promoter in a lentiviral 
vector (1). 
 
RNA isolation from cells, reverse transcription, real-time PCR 
Total RNA was extracted with Trizol Reagent. One µg RNA was reverse-transcribed with 
Superscript III (Invitrogen). Real-time PCR was performed in 25µl with SybrGreen Supermix 
(BioRad, Marnes-la-Coquette, France). The sequences of primers used are in Supporting 
Table 2. Five µl of a 50-fold dilution of cDNA were used as template. 
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Northern blot 
Fifteen µg total RNA was separated by electrophoresis into a formaldehyde-agarose gel (1.2% 
agarose). At the end of migration, RNAs were transferred by capillarity and UV-cross linked 
on a HyBond N+ nylon membrane. 
The probes used were the full-length Pontin and Reptin cDNA, purified after restriction 
digestion of plasmids CBF-Tip48 and CBF-Tip49 (4). The probes were radio-labeled using 
5ng of template DNA with α32P-dCTP by random priming labeling according to the 
supplier’s instruction (GE Healthcare Ready-to-Go DNA Labelling Beads). Hybridization 
was performed for 16 hours at 42°C in Expresshyb™ Hybridization solution (Clontech, BD). 
The signals were acquired in an Instant-Imager. 
 
 
 
 
Supporting Figure legends 
 
Supporting Fig. 1. Specificity of Reptin and Pontin antibodies 
(A) Recombinant Reptin and Pontin were subjected to immunoblot analysis simultaneously 
with mouse mAb Reptin (left) and rabbit pAb Pontin (right). Detection was achieved with 
infrared dye-labeled secondary goat anti-mouse (green) and goat anti-rabbit (red). No band 
was detected with the Reptin antibody (green) in the lane containing purified Pontin and no 
band was detected with the Pontin antibody (red) in the lane containing purified Reptin. (B) 
HuH7 cells were transfected with either CBF-Tip48 (Flag-Reptin) or CBF-Tip49 (Flag-
Pontin). Cells were harvested 72h after transfection, and extracts were subjected to Western 
blot analysis with the indicated antibodies. (C) Co-depletion of Pontin and Reptin shown in 
HuH7 cells 3 days after transfection of siRNA revealed using several other antibodies. Reptin 
(MC) and Pontin (MC) antibodies were a gift from M. Cole (4). Reptin (2E9-5) antibody was 
a gift from O. Huber (5). 
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 4 
Supporting Fig. 2. Design of Pontin and Reptin siRNA-resistant cDNAs 
Schematic representation of the HA-tagged Pontin and Flag-tagged Reptin cDNA sequences. 
The Pontin-siRNA(P2) targeted sequence and the Reptin-siRNA (R2) targeted sequences are 
indicated by capital letters. Silent mutations are indicated by bold/italic letters. 
 
Supporting Fig. 3. Co-depletion of Pontin and Reptin occurs in a variety of cell lines 
from several species 
Western blot of Pontin and Reptin expression in several cell lines transfected with control 
siRNA (GL2, scR or scP) or Reptin specific siRNA (R1, R2) or Pontin specific siRNA (P1, 
P2). The relative amounts of Pontin and Reptin below the lanes were estimated by 
densitometry and are shown below the blots. NT: non transfected. HepG2, MCF7, FAO, Hepa 
1-6 and Hela cells were cultured in Dulbecco’s modified Eagle’s media, supplemented with 
10% fetal bovine serum (FBS), non essential amino acids, L-glutamine, and 
penicillin/streptomycin in 5% CO2 –containing atmosphere at 37°C. LNCap cells were 
cultured in RPMI, supplemented with 10% FBS, non essential amino acids, L-glutamine, and 
penicillin/streptomycin in Corning® CellBIND® Surface plates in 5% CO2 –containing 
atmosphere at 37°C. 
siRNAs were transfected at a concentration of 125nM into HepG2, Hepa1-6, FAO, MCF7 and 
HeLa cells with Lipofectamine (Invitrogen, Cergy Pontoise, France). We used the 
Nucleofector technology (Amaxa) to transfect siRNAs in LNCap cells (20pmol of siRNA for 
106 cells).  
 
Supporting Fig. 4. Co-depletion of ectopically-expressed proteins 
(A) Knock-down of Pontin leads to down-regulation of endogenous Reptin and of ectopically 
expressed Flag-Reptin in HuH7 cells. HuH7 cells that stably express a N-term Flag-tagged 
Reptin from the MND viral promoter were transfected with the indicated siRNAs. Three days 
after transfection, the cells were lysed and processed for western blot with antibodies specific 
to Reptin, FLAG tag and β-actin. The arrow indicates the migration of Flag-tagged Reptin. 
This experiment shows that both endogenous and ectopically-expressed Reptin were depleted 
with Pontin siRNAs. In order to rule out a possible confounding factor, we first checked that 
Pontin was not required for transcription from the MND promoter by demonstrating that the 
expression of GFP driven by the MND promoter was not altered in Pontin-depleted cells (not 
shown). (B) Co-depletion of ectopically expressed Pontin and Reptin and endogenous 
proteins in Hela cells. Western blot of Reptin and Pontin expression in siRNA transfected 
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 5 
Hela cell lines that stably expressed a N-term Flag-HA-tagged Reptin (FH-Reptin) or FH-
Pontin from CMV promoter. Three days after transfection of siRNAs, the cells were lysed and 
processed for western blot with antibodies specific to Reptin, Pontin and β-actin. 
 
Supporting Fig. 5. Co-depletion in cells expressing an inducible Reptin shRNA 
(A) Knock-down of Reptin with an inducible shRNA vector leads to down-regulation of 
Pontin in HuH7. Western blot of Pontin and Reptin expression in HuH7 cell lines stably 
transduced to express either the GL2 shRNA (against firefly luciferase, KGL2 cells) or the R2 
shRNA (against Reptin, KR2 cells) in a doxycycline-dependent manner. Four days after 
adding of doxycyline in the culture medium, the cells were lysed and processed for western 
blot with antibodies specific to Pontin, Reptin and β-actin. Protein levels of Reptin and Pontin 
were decreased by 72% ± 15% and 84% ± 15%, respectively, four days after addition of 
doxycycline in KR2 cells, whereas they remained stable in KGL2 cells. (B) Pontin mRNA 
level is not decreased in response to Reptin shRNA expression. Real-time PCR analysis of 
Reptin and Pontin cDNAs from KR2 cells treated or not with doxycyline during 48h. The 
results show the expression of Reptin and Pontin in doxycycline treated KR2 cells normalized 
to untreated cells (set as 100%) and are the mean ± 1 SD of three independent experiments. 
GAPDH mRNA level is used as a standard. 
 
Supporting Fig. 6. Lack of evidence for Pontin or Reptin ubiquitylation  
(A) No evidence for Pontin ubiquitylation following Reptin silencing. KR2 cells were grown 
for 3 days after infection by an adenoviral vector expressing HA-Ubiquitin + GFP, or GFP 
alone in medium supplemented or not with doxycycline. After 4 hours of treatment with 
2.5µM epoxomycin, cells were lysed in lysis buffer supplemented with 10 mM N-
ethylmaleimide and 2 mM DTT, and expression of HA-ubiquitinylated proteins and GFP was 
detected in the input (left). Ubiquitylated proteins were immunoprecipitated using an anti-HA 
monoclonal antibody (right). The overall profile of ubiquitylated proteins was not altered by 
Reptin silencing (top panel). Ubiquitylated β-catenin was readily detected in the 
immunoprecipitate (middle panel). In contrast, ubiquitylated Pontin could not be detected 
(lower panel). (B) No evidence for Reptin ubiquitylation following Pontin silencing. Same as 
in (B) except that KP2-FR cells were used. 
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 6 
Supporting Fig. 7. Kinetics of co-depletion 
(A) HuH7 cells were transfected with the indicated siRNAs and protein expression was 
monitored by Western blot at various time points. (B) KR2 cells were grown in medium 
supplemented or not with doxyxcycline and Pontin or Reptin protein expression was 
monitored by Western blot at various time points. 
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Supporting Table 1. Patients characteristics and histology of the surrounding liver 
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